proxyvotesnow.com

Home › Asset managers › Compare 2024-2025 › Charles Schwab vs Brighthouse

Charles Schwab vs Brighthouse: how alike they voted, 2024-2025

57.1% When both took a single position, they voted the same way on 57.1% of 9,033 items (5,158 the same, 3,875 different). 12,282 items where at least one of them split its funds are listed separately below. Both voted on 21,315 items in all.

Note on Brighthouse: its funds did not all vote the same way on 14.7% of the 97,681 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.

Charles Schwab 2024-2025 · Brighthouse 2024-2025 · Download the item list (CSV)

By who put the item on the ballot. “Same position” = Same / (Same + Differ); split items are not in it. “Fund-level” is a second view over all common items: the chance that a fund of each manager, picked at random, voted the same way, which gives partial credit where a manager split.
Common itemsSame DifferSplit (not in %)Same position Fund-level
All ballot items 21,3155,1583,875 12,28257.1%60.9%
Board proposals 20,0274,7393,782 11,50655.6%60.8%
E&S shareholder proposals 284257 25278.1%45.0%
Other items 1,00439486 52482.1%66.4%

Where they did not vote alike

Everything Voted differently Split votes

All ballot items Board proposals E&S shareholder proposals Other items

610 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.

CompanyMeetingProposalOn the ballot from Board recommendedCharles SchwabBrighthouse
WESCO INTE May 22, 2025 Approve amendments to the Company's Restated Certificate of Incorporation to provide Stockholders with the right to request a special meeting of stockholders.
Corporate Governance
Other Not determined FOR
12 funds
Split
9 FOR, 1 ABSTAIN
WESCO INTE May 22, 2025 Shareholder proposal to give Shareholders the ability to call for a special shareholder meeting.
Corporate Governance
Other Not determined AGAINST
12 funds
Split
5 FOR, 4 AGAINST, 1 ABSTAIN
WEST PHARMACEUTICAL SERVICES INC. May 6, 2025 Amend and Restate Our Amended and Restated Articles of Incorporation to Add a Right For Shareholders to call a Special Meeting.
Shareholder Rights and Defenses
Other For FOR
14 funds
Split
9 FOR, 2 ABSTAIN
WEX INC. May 15, 2025 To approve an Amendment to the Company's Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.
Director Elections
Other For FOR
14 funds
Split
3 FOR, 1 AGAINST, 1 ABSTAIN
WORKIVA INC. May 29, 2025 Approval of the amendment of Workiva's Certificate of Incorporation to allow for the exculpation of officers as permitted by Delaware law.
Director Elections
Other For FOR
5 funds
Split
3 AGAINST, 2 ABSTAIN
XOMA ROYALTY CORP. May 28, 2025 Approval of a proposal to authorize the Board to unilaterally amend the By-laws.
Shareholder Rights and Defenses
Other For AGAINST
2 funds
Split
1 FOR, 1 ABSTAIN
XOMA ROYALTY CORP. May 28, 2025 Approval of an adjournment of the annual meeting, if necessary or appropriate, to solicit additional proxies.
Corporate Governance
Other For FOR
2 funds
Split
1 AGAINST, 1 ABSTAIN
XYLEM May 13, 2025 Shareholder proposal to lower threshold for shareholders to call special meetings from 25% to 10% of Company stock, if properly presented at the meeting.
Corporate Governance
Other Against AGAINST
13 funds
Split
5 FOR, 2 ABSTAIN
ZIMMER BIO May 29, 2025 Approve an amendment to our Restated Certificate of Incorporation to allow for exculpation of officers as permitted by Delaware law.
Corporate Governance
Other Not determined FOR
15 funds
Split
7 FOR, 2 ABSTAIN
ZOETIS INC. May 21, 2025 Shareholder proposal regarding a special shareholder meeting improvement.
Corporate Governance
Other Against AGAINST
14 funds
Split
1 FOR, 5 AGAINST, 4 ABSTAIN

← Previous Page 7 of 7

← All 20 managers, 2024-2025

How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.